Introduction
In 1953, Scully 1 first described classical gonadoblastoma and, in a seminal paper 17 years later, he reported a series of 74 cases. 2 In 2006, Cools et al. 3 proposed that classical gonadoblastoma arises from undifferentiated gonadal tissue within the dysgenetic gonads of an individual who has a disorder of sex development. Since that time, the concept has been accepted widely. [4] [5] [6] [7] [8] Recently, however, Kao et al. 9 proposed a different model in which classical gonadoblastoma was said to arise from the recently described entity of 'dissecting gonadoblastoma', despite the fact that in some cases they also considered the latter to be the precursor of germinoma. Subsequent to the publication of the 2016 WHO classification of testicular tumours, the same group proposed that 'dissecting gonadoblastoma' could be used as a synonym for undifferentiated gonadal tissue rather than to replace the latter term. 10 In this paper, we investigate whether classical gonadoblastoma arises from undifferentiated gonadal tissue or from 'dissecting gonadoblastoma' and discuss the relationship of classical and 'dissecting' gonadoblastoma to germinoma and other malignant germ cell tumours ( Figure 1 ). We also consider the possible implications of the usage of the term 'dissecting gonadoblastoma' in the clinical management of patients with a disorder of sex development.
Classical gonadoblastoma and related entities C L I N I C A L F E A T U R E S
Classical gonadoblastoma occurs almost entirely in the dysgenetic gonads of an individual who has a disorder of sex development and a Y chromosome or part thereof. 4, 11 It occurs predominantly in phenotypical females with gonadal dysgenesis and an abnormal karyotype, but occurs exceptionally in apparently normal females with a 46, XX karyotype. 12 Approximately 20% of classical gonadoblastomas occur in phenotypical males, who are most often <20 years of age. 13 The clinical presentation in the latter patients commonly includes cryptorchidism, hypospadias and gynaecomastia. 2 The most common predisposing conditions are 45, X/46, XY partial gonadal dysgenesis, 46, XY complete gonadal dysgenesis and 46, XY disorder of sex development. 4, 14 By definition, at least one gonad is developmentally abnormal in patients who have a disorder of sex development; however, the abnormality would not be detected histologically if the gonad had been replaced completely by neoplasm prior to operation. 
M O L E C U L A R A N D G E N E T I C F I N D I N G S
The gonadoblastoma susceptibility region on the short arm of the Y chromosome is the only oncogenic area on the human Y chromosome and predisposes the dysgenetic gonads of XY individuals to develop a non-invasive tumour; testis specific protein Y-linked 1 (TSPY1) is the putative gene. [15] [16] [17] [18] If a gonad in a patient who has a disorder of sex development contains germ cells with delayed maturation and also harbours the TSPY1 gene, the cells may undergo transformation to classical gonadoblastoma. 19 The germ cells that have delayed maturation express octamer-binding transcription factor 4 (OCT4). 3 M A C R O S C O P I C A P P E A R A N C E Pure classical gonadoblastoma typically measures <8 cm in greatest dimension, and the consistency varies from soft and fleshy to firm. The sectioned surface of gonadoblastoma varies from brown to yellow or grey. White flecks of calcification often occur. If concurrent germinoma is present the neoplasm can be larger, and the malignant component has a soft, pale grey appearance (Figure 2A ).
Classical gonadoblastoma is a non-invasive neoplasm composed of rounded islands or nests of cells surrounded by a variably cellular stroma. Approximately 40% of gonadoblastomas are bilateral. 7 Histologically, the islands are composed of germ cells admixed intimately with immature sex cord derivatives, and the latter often surround hyaline basement membrane deposits or occasionally calcifications ( Figure 2B ). At times, the stroma between the islands is cellular, resembling gonadal stroma and, in some instances, stromal steroid cells are noted. Crystals of Reinke are not identified. The germ cells of individual cases of gonadoblastoma are heterogeneous, being composed of both mature and immature forms. 7 Frequently, classical gonadoblastoma shows involutional changes including deposits of hyalinised basement membrane material and calcification. Rarely, the involutional changes are extensive, resulting in a calcified mass without any viable neoplastic cells. We refer to such cases as involuted gonadoblastoma, although such cases were described originally as 'burnt out' gonadoblastoma. 2 Classical gonadoblastoma contains two types of germ cells; the germinoma-like cells are considered to be the precursor of the malignant germ cell neoplasms associated with gonadoblastoma. However, other germ cells resemble spermatogonia. 20 The mature germ cells express TSPY1, whereas the immature germ cells express OCT4 ( Figure 2C ). 21 Only a small subpopulation of germ cells in classical gonadoblastoma coexpresses both antibodies. 21 The sex cord cells show nuclear expression of steroidogenic factor 1 and cytoplasmic expression of a-inhibin (Figure 2D) .
The transcription factors SRY-box 9 (SOX9) and forkhead box L2 (FOXL2) are required for male and female mammalian gonadal development, respectively. 22 In patients with a sex development disorder, testicular differentiation in dysgenetic gonads can be visualised utilising SOX9, and ovarian differentiation can be visualised using FOXL2.
U N D I F F E R E N T I A T E D G O N A D A L T I S S U E
In a seminal paper, Cools et al. 3 first introduced the concept of undifferentiated gonadal tissue. The latter is defined as gonadal tissue containing germ cells not enclosed in seminiferous tubules or follicles that either resides without apparent organisation in a background of cellular gonadal stroma or is organised together with sex cord elements into cord-like structures. 3 Undifferentiated gonadal tissue occurs exclusively within dysgenetic gonads of patients who have a Y chromosome or part thereof, and has been described morphologically as surviving germ cells with delayed development within immature sex cords or isolated in the interstitium. 3 As such, undifferentiated gonadal tissue is strictly a histological diagnosis. Expression of OCT4 in undifferentiated gonadal tissue is useful in determining maturation delay of germ cells and, thus, the risk for tumorigenesis in dysgenetic gonads. 23 Macroscopically, the dysgenetic gonads of a patient with a disorder of sex development in cases lacking a neoplasm have the appearance of a streak. It is important to realise that the gonads of a patient with a disorder of sex development and a Y chromosome or part thereof are often histologically heterogenous, showing various differentiation patterns as illustrated in Figure 2G of Cools et al. 4 Areas of undifferentiated gonadal tissue, ovarian tissue, dysgenetic testicular tissue and secondary streak, as well as neoplasms, can occur in any combination. Undifferentiated gonadal tissue is typically a component of the dysgenetic gonad in patients who have a Y chromosome or part thereof. Maturation-delayed germ cells occurring in dysgenetic testicular tubules should be distinguished from undifferentiated gonadal tissue in these gonads. 24 At low magnification, dysgenetic gonads have a convex surface that overlies cellular gonadal stroma (Figure 3A) . In some instances, the sex cord elements of undifferentiated gonadal tissue are inconspicuous (Figure 3B ). However, even when they are more abundant, they blend into the surrounding gonadal stroma in a seamless manner on haematoxylin and eosin stains ( Figure 3C ). Immunocytochemical stains, however, serve to accentuate the cord-like structures. The sex cord elements show nuclear expression of steroidogenic factor 1 and cytoplasmic expression of a-inhibin ( Figure 3D ).
S T R E A K G O N A D S
Macroscopically, streak gonads are elongated pale white structures located in the mesosalpinges. 25 They are best known for their occurrence in Turner syndrome in patients with a 46, X karyotype. These patients lack a Y chromosome or part thereof. However, Cools et al. 3 described a different type of streak that occurs as a result of loss of germ cells from undifferentiated gonadal tissue in patients who have a Y chromosome or part thereof. We refer to the latter form as a secondary streak, in contrast to the streaks that occur in Turner syndrome that we refer to as primary streaks.
Histologically, dysgenetic (streak) gonads have a convex surface that overlies cellular gonadal stroma ( Figure 4A ). In well-preserved tissue from a streak gonad, a surface lining of mesothelium that overlies a thin tunica albuginea is apparent ( Figure 4B ). The latter, in turn, overlies cellular gonadal stroma (Figure 4C) . Residual sex cords lacking germ cells can be identified in some secondary streaks, a histological feature that distinguishes the latter from primary streak gonads ( Figure 4D ). Although patients who have a primary streak gonad and lack the Y-chromosome or part thereof (Turner syndrome) have a negligible risk of developing classical gonadoblastoma or a malignant germ cell tumour, an important finding of our review of the data of Cools et al. 3 and Beaulieu Bergeron et al. 5 is that patients with a secondary streak have a risk of developing gonadoblastoma similar to that of undifferentiated gonadal tissue. This observation suggests that classical gonadoblastoma develops before the complete loss of germ cells in the dysgenetic gonads of patients with a disorder of sex development.
In patients who have a disorder of sex development with a Y chromosome or part thereof, delayed maturation of germ cells is a histological feature of their dysgenetic gonads. Maturation delay of germ cells occurs in both undifferentiated gonadal tissue and dysgenetic testicular tissue, and an association exists between the two. 24 Undifferentiated gonadal tissue is the precursor of gonadoblastoma, and dysgenetic testicular tissue is the precursor of germ cell neoplasia in situ.
3 Maturation delay of germ cells is a protective mechanism for survival of germ cells in a harsh environment; however, prolonged expression of OCT4 in maturation-delayed germ cells is considered to be a risk factor for malignant transformation.
C L A S S I C A L G O N A D O B L A S T O M A
Undifferentiated gonadal tissue in dysgenetic gonads has been proposed as the precursor of classical gonadoblastoma. 3 In 67% of cases of classical gonadoblastoma that contained adjacent gonad, undifferentiated gonadal tissue was identified. 3 The germ cells in both undifferentiated gonadal tissue and classical gonadoblastoma are heterogeneous; they can express TSPY1 or OCT4, or can coexpress the two. 21 Clonal expansion of germ cells and final organisation in undifferentiated gonadal tissue may be the last step in the transition to classical gonadoblastoma. 3 It is of interest that the cellular gonadal stroma characteristic of undifferentiated gonadal tissue is sometimes also a component of classical gonadoblastoma, although it is considerably less conspicuous in the latter.
D Y S G E N E T I C T E S T I C U L A R T I S S U E
In 2006, Cools et al. 3 recognised, and in the following year Looijenga et al. 23 described in greater detail, a second precursor of germ cell malignancy in patients with a disorder of sex development and a Y chromosome or part thereof, germ cell neoplasia in situ originating in dysgenetic testicular tissue. Although classical gonadoblastoma is the precursor of germinoma in dysgenetic gonads lacking obvious testicular tissue, germ cell neoplasia in situ is the immediate precursor of germinoma in testicular areas. 4 In patients with undervirilisation syndromes, it is often difficult to distinguish maturation delay from germ cell neoplasia in situ in dysgenetic testicular tissue; however, patient age and the position of OCT4-expressing cells within dysgenetic seminiferous tubules may be helpful in some cases. 19 In dysgenetic testicular tissue with maturation delay the germ cells expressing OCT4 are located in the central portion of the tubule, whereas in germ cell neoplasia in situ they have migrated toward the basement membrane. Expression of the c-KIT ligand stem cell factor was demonstrated to be useful in distinguishing germ cell neoplasia in situ from maturation delay of germ cells in dysgenetic gonads. 26 Stem cell factor was expressed in all cases of germ cell neoplasia in situ and gonadoblastoma, but not in infantile testicular tissue.
In 2016, Lepais et al. 24 proposed a novel histological approach for assessment of gonads of patients with a disorder of sex development. They studied 175 samples from 86 patients and analysed gonads according to a strict histological interpretation protocol. They used the term testicular 'dysplasia' to describe the architectural disorganisation of the testicular portion of the gonad and specifically excluded the use of the term 'gonadal dysgenesis' as a pathological diagnosis. However, there is a precedent for the use of the term 'testicular dysgenesis syndrome' in reference to pathological findings, as it was applied previously to describe cases of germ cell neoplasia in situ associated with testicular environmental disorders. 27 Moreover, we believe that the terminology of Lepais et al. 24 is suboptimal, as the term testicular 'dysplasia' had been used previously to describe a different testicular lesion. In the original usage, the term 'cystic dysplasia of the testis' was used to describe cystic dilatation of the rete testis with secondary compression of the testicular parenchyma. 28 Furthermore, we are not aware of prior usage of the term 'dysplasia' in patients with a disorder of sex development. In the field of pathology, the term 'dysplasia' refers to alteration in size, shape and organisation of adult cells. We prefer the established term 'dysgenetic testicular tissue', that refers more specifically to defective development.
Lepais et al. 24 identified five histological categories for the gonads of patients with a disorder of sex development: normal gonad, hypoplastic testis, 'dysplastic' testis, streak gonad and ovotestis. Criteria for dysgenetic testicular tissue, our preferred term for 'dysplastic' testis, include irregular, branched seminiferous tubules, thin tunica albuginea and fibrous interstitium. 24 Gonadal biopsies would not be adequate for use of this classification, as variability from area to area in the dysgenetic gonad could result in sampling error.
' D I S S E C T I N G G O N A D O B L A S T O M A '
Late in Dr Robert E. Scully's career, he recognised two histological growth patterns of gonadoblastoma that were confused easily with germinoma; the first were large confluent expanded nests and the second consisted of clusters and cords. 9 He referred to this histological variant as 'dissecting (infiltrating) gonadoblastoma'; however, these observations were not published during his lifetime.
In a recent investigation of 50 cases of classical gonadoblastoma, Kao et al. 9 described a morphological variant in 38 of these cases that they referred to as 'dissecting gonadoblastoma'. They considered the latter to be a variant of classical gonadoblastoma that showed similar immunohistochemical findings. Involutional changes are less frequent in the 'dissecting' variant than in classical gonadoblastoma, suggesting that the latter is a more stable lesion ( Figure 5A ). In their model, classical gonadoblastoma was proposed to be the intermediate lesion between the cord-like/ anastomosing phase and the solid/expansive form of 'dissecting gonadoblastoma'.
The prime importance of this variant is that several growth patterns in which the number of sex cord cells appear reduced can be misinterpreted as germinoma. 9 They described three patterns: solid expansive, anastomosing and cord-like. The solid expansive and cord-like patterns, in particular, can be confused with similar patterns that have been described in germinoma resulting in more aggressive clinical treatment than necessary ( Figure 5B ). The application of a-inhibin or steroidogenic factor 1 immunocytochemical stains facilitates the identification of residual sex cord elements and is often useful in distinguishing 'dissecting gonadoblastoma' from germinoma. 9 
D I S T I N C T I O N O F U N D I F F E R E N T I A T E D G O N A D A L T I S S U E F R O M ' D I S S E C T I N G G O N A D O B L A S T O M A '
The relationship of 'dissecting gonadoblastoma' to undifferentiated gonadal tissue is controversial and has not been resolved completely. Recently, it was proposed that 'dissecting gonadoblastoma' either replace or be used as a synonym for the term 'undifferentiated gonadal tissue'. 9, 10 In our opinion, however, it is preferable to continue to use the well-established term undifferentiated gonadal tissue for those cases that are considered to be the precursor of classical gonadoblastoma, as was recommended in the latest WHO classification of testicular tumours (p. 237), and to limit the use of the term 'dissecting gonadoblastoma' to those cases with solid expansive, cord-like or other patterns that can be confused with germinoma. 7 We do not believe that the term 'dissecting gonadoblastoma' should be used as either a substitute or synonym for undifferentiated gonadal tissue.
Both undifferentiated gonadal tissue and 'dissecting gonadoblastoma' occur in patients with a disorder of sex development; they differ, however, in that undifferentiated gonadal tissue is a non-neoplastic condition, whereas 'dissecting gonadoblastoma' is a neoplasm with the potential for progression to germinoma. Because of the current controversy in the literature, we will discuss in detail the clinical, macroscopic and histological differences between the two lesions and also examine the clinical importance of making this distinction.
Macroscopically, streak gonads are elongated pale white structures located in the mesosalpinges. Classically, primary streaks occur in patients with 46, X Turner syndrome and are unaccompanied by a concomitant neoplasm, whereas undifferentiated gonadal tissue and secondary streaks occur in patients who have a Y chromosome or part thereof. By way of contrast, 'dissecting gonadoblastoma' would occur macroscopically as a gonadal mass in the great majority of cases, as the cases of Kao et al. 9 were associated invariably with classical gonadoblastoma.
Histologically, undifferentiated gonadal tissue consists of gonadal stroma that contains maturationdelayed germ cells either individually within the gonadal stroma or within immature sex cords. The individual germ cells and immature sex cords blend into the underlying gonadal stroma on haematoxylin and eosin stains ( Figure 6A ). Both the individual germ cells and the sex cords appear to belong in and be an element of the surrounding gonadal stroma. In contrast, the aggregates of 'dissecting gonadoblastoma' are demarcated sharply on haematoxylin and eosin stains and stand out from the underlying gonadal stroma in a fashion similar to that of classical gonadoblastoma ( Figure 6B ). A caveat, however, is the observation that the cords in undifferentiated gonadal tissue stand out and are accentuated by immunohistochemical stains; thus, the distinction between undifferentiated gonadal tissue and 'dissecting gonadoblastoma' must be made on haematoxylin and eosin-stained sections in order to avoid a possible misinterpretation.
Gonadal stroma is typically the predominant component of undifferentiated gonadal tissue, whereas the germ cell and sex cord component is usually more prominent in 'dissecting gonadoblastoma'; however, exceptions are not infrequent. In some instances, 'dissecting gonadoblastoma' has an expansive growth pattern with proliferation of transformed germ cells; however, no desmoplastic reaction is identifiable. Clonal expansion of germ cells in 'dissecting gonadoblastoma' is the likely immediate precursor of some germinomas. Although there is no direct association of undifferentiated gonadal tissue with malignant germ cell tumours, there is a clear association of classical, involuted and 'dissecting' gonadoblastoma to the aforementioned neoplasms.
In summary, we believe that it is essential for optimal patient care to distinguish undifferentiated gonadal tissue from 'dissecting gonadoblastoma' because the former is a non-neoplastic condition, whereas the latter is a neoplasm that is a precursor of germinoma in some cases. Failure to make this distinction might result in some patients with a disorder of sex development receiving more aggressive treatment than necessary.
R E L A T I O N S H I P O F C L A S S I C A L A N D ' D I S S E C T I N G '
Cools et al. 4 classified patients with a disorder of sex development into four risk categories, high, intermediate, low and unknown, depending on their risk of developing a malignant germ cell neoplasm. An associated malignant germ cell tumour is encountered in 60% of cases of classical gonadoblastoma, and in 80% of the latter cases the neoplasm is germinoma ( Figure 7A ). 29 We are aware of three precursors of a malignant germ cell neoplasm in patients with a disorder of sex development. Classical gonadoblastoma represents a major precursor of germinoma. 30 However, in some cases 'dissecting gonadoblastoma' is the immediate precursor of germinoma ( Figure 7B) . A third, less common, precursor is germ cell neoplasia in situ that arises in dysgenetic testicular tissue. 4, 17, 24 Patients with classical gonadoblastoma and germinoma sometimes develop a more aggressive germ cell neoplasm, including yolk sac tumour, embryonal carcinoma or teratoma. 31 Germinoma occurred in 22 cases of classical gonadoblastoma that also had a 'dissecting' component, and three germinomas were associated with another malignant germ cell component. 9 No non-germinomatous malignant germ cell neoplasms occurred in the absence of germinoma. Although the numbers are small, this observation suggests that other malignant germ cell tumours arise not uncommonly from germinoma.
The term 'dissecting gonadoblastoma' was introduced in 2016; however, its solid/expansive pattern, in particular, seems inconsistent with the term 'dissecting'. Alternative terminology to be considered would be gonadoblastoma variant with unusual growth patterns. However, we believe that in order to avoid possible misinterpretation in the literature the choice of preferred terminology should be left to a future consensus committee.
P A T I E N T A D V O C A C Y G R O U P S
Patient advocacy groups are currently demanding a more conservative clinical approach whenever possible with regard to possible gonadectomy in patients with a disorder of sex development. 4 More specifically, the conservative approach includes delay of gonadectomy in patients whenever medically feasable to allow for maximum patient and parental input into gender assignment and, thus, such an approach ensures that the patient's sex assignment fits their wishes most effectively. 32 The most important factors that influence gender assignment include an accurate clinical and histological diagnosis, the appearance of the external genitalia, the possible surgical options, the potential for fertility, the risks of gonadal malignancy and, importantly, the gender perception of the patient and parents. 32 Full disclosure and complete involvement of the parents in making decisions concerning gender assignment and/or genital surgery must be a factor in the basic medical care for infants and young children with a disorder of sex development.
Conclusions
It is important to distinguish undifferentiated gonadal tissue from 'dissecting gonadoblastoma' because patient management, risk of progression and prognosis are distinctly different for the two entities. Undifferentiated gonadal tissue occurs in the dysgenetic gonads of patients who have a Y chromosome or part thereof and is the precursor of classical gonadoblastoma, whereas 'dissecting gonadoblastoma' is a variant of classical gonadoblastoma that can progress to germinoma.
Patient advocacy groups are currently demanding a more conservative approach whenever possible with regard to possible gonadectomy in patients with a disorder of sex development. More specifically, the conservative approach includes delay of gonadectomy in patients whenever medically feasable to allow for maximum patient and parental input into gender assignment. The ultimate functionality of the gonad is highly relevant to this decision.
